Neuromodulation Market
According to Intent Market Research, the Neuromodulation Market is expected to grow from USD 6.4 Billion in 2024-e at a CAGR of 9.8% to touch USD 11.2 Billion by 2030. The Neuromodulation Market is dominated by key players such as, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corp., Synapse Biomedical Inc., and LivaNova PLC.